DEPLOYDatabase

Robot model

Oryom

The JASPER Platform (formerly ORYOM) is the world's first robotic surgery platform for cataract and widespread ocular diseases.

Track Oryom
Manufacturer
ForSight Robotics
Form factor
surgical
Maturity
pilot
Lifecycle
active
Deployments
1
Website
forsightrobotics.com ↗

The verified answer

As of Aug 2026, DEPLOY verifies Oryom, a surgical by ForSight Robotics (pilot): 1 verified deployment on record. 1 source back the record.

Overview

The JASPER Platform (formerly ORYOM) is the world's first robotic surgery platform for cataract and widespread ocular diseases. It combines a 14-degree-of-freedom microsurgical robotic hand, 3D image guidance with segmentation, and AI-based data analytics to replicate and enhance conventional cataract surgery workflow. In April 2026, it performed the first fully robot-assisted cataract surgery in a human patient without general anesthesia.

Verified vs. claimed

Maturity stage
pilot(Small-scale deployment in controlled or trial conditions.)
Verified deployments
1 deployment on file
Sources on file
1 source, view all

Data & sources

Web sources

1

1 source backing this record.View all →

Autonomy: verified vs claimed

What it actually does
Teleoperated (human-controlled)

Pricing

No verified price is on record for Oryom. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (1)

Oryom on the deployment map

Where Oryom is verified operating. Explore the deployment map by place and type.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Oryom.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://forsightrobotics.com/newsroom/forsight-robotics-secures-125m-in-series-b-funding-addressing-global-surgeon-shortage-and-exploding-demand-for-ophthalmic-surgery

Common questions

What is Oryom?
The JASPER Platform (formerly ORYOM) is the world's first robotic surgery platform for cataract and widespread ocular diseases. It combines a 14-degree-of-freedom microsurgical robotic hand, 3D image guidance with segmentation, and AI-based data analytics to replicate and enhance conventional cataract surgery workflow. In April 2026, it performed the first fully robot-assisted cataract surgery in a human patient without general anesthesia.
How much does Oryom cost?
Oryom's price is not publicly disclosed. DEPLOY has no verified price on record for Oryom from ForSight Robotics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Oryom actually deployed in the real world?
Yes. Oryom is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Oryom?
Oryom is made by ForSight Robotics, based in Yokneam Illit, Israel, founded in 2020.
Where is Oryom deployed?
1 verified deployment of Oryom is on the DEPLOY registry, including at Manila, Philippines.
Can you buy Oryom?
Oryom is in pilot deployments with named customers and is not yet broadly for sale.
What are alternatives to Oryom?
On the DEPLOY registry, comparable surgical robots to Oryom include Toumai, da Vinci (and Ion), Epione, Hugo RAS.
How does Oryom compare to Toumai?
Oryom and Toumai (MicroPort MedBot · 8 deployments) are both surgical robots on the DEPLOY registry. Oryom has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
What is Oryom's maturity stage?
Oryom is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
Is Oryom safe?
Oryom has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Unreviewed · 1 source (no primary) · last reviewed 2026-08-03

Verification posture

Unreviewed

Low confidence

Review state

Stable

Last reviewed 2026-08-03

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Oryom.